Reuters logo
7 天前
BRIEF-Protalix Biotherapeutics qtrly loss per share from continuing operations $0.47 ​
2017年8月9日 / 中午11点34分 / 7 天前

BRIEF-Protalix Biotherapeutics qtrly loss per share from continuing operations $0.47 ​

1 分钟阅读

Aug 9 (Reuters) - Protalix Biotherapeutics Inc:

* Protalix Biotherapeutics reports 2017 second quarter results and provides corporate update

* Qtrly ‍revenues $6.4 million versus $1.8 million; qtrly loss per share from continuing operations $0.47 ​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below